BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dwyer BJ, Jarman EJ, Gogoi-Tiwari J, Ferreira-Gonzalez S, Boulter L, Guest RV, Kendall TJ, Kurian D, Kilpatrick AM, Robson AJ, O'Duibhir E, Man TY, Campana L, Starkey Lewis PJ, Wigmore SJ, Olynyk JK, Ramm GA, Tirnitz-Parker JEE, Forbes SJ. TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progression. J Hepatol 2021;74:860-72. [PMID: 33221352 DOI: 10.1016/j.jhep.2020.11.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Fabris L, Cadamuro M, Fouassier L. Illuminate TWEAK/Fn14 pathway in intrahepatic cholangiocarcinoma: Another brick in the wall of tumor niche. J Hepatol 2021;74:771-4. [PMID: 33583626 DOI: 10.1016/j.jhep.2020.12.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Karagianni AE, Eaton SL, Kurian D, Cillán-Garcia E, Twynam-Perkins J, Raper A, Wishart TM, Pirie RS. Application across species of a one health approach to liquid sample handling for respiratory based -omics analysis. Sci Rep 2021;11:14292. [PMID: 34253818 DOI: 10.1038/s41598-021-93839-9] [Reference Citation Analysis]
3 Li G, Zhang Z, Cai L, Tang X, Huang J, Yu L, Wang G, Zhong K, Cao Y, Liu C, Wang Y, Tong A, Zhou L. Fn14-targeted BiTE and CAR-T cells demonstrate potent preclinical activity against glioblastoma. Oncoimmunology 2021;10:1983306. [PMID: 34595061 DOI: 10.1080/2162402X.2021.1983306] [Reference Citation Analysis]
4 Gupta G, Kazmi I, Al-Abbasi FA, Singh Y, Roshan S, Rani S, Mishra A, Prasher P, Jha NK, Thangavelu L, Dureja H, Singh SK, Bhatt S, Chellappan DK, Dua K. Activation of TWEAK/Fn14 signaling suppresses TRAFs/NF-?B pathway in the pathogenesis of cancer. EXCLI J 2021;20:232-5. [PMID: 34121970 DOI: 10.17179/excli2021-3378] [Reference Citation Analysis]
5 Li C, Zhao X, Gu X, Chen Y, Yu G. The Preventive Role of Hydrogen-Rich Water in Thioacetamide-Induced Cholangiofibrosis in Rat Assessed by Automated Histological Classification. Front Pharmacol 2021;12:632045. [PMID: 34489690 DOI: 10.3389/fphar.2021.632045] [Reference Citation Analysis]